Amgen Inc - Stock Based Compensation

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Stock-Based-Compensation" stands at 0.66 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Amgen Inc's third quarter result of 0.284 Billion USD for the item "Stock Based Compensation" represents an increase of 80.89 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 0.284 Billion USD for the item "Stock Based Compensation" represents an increase of 108.82 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 0.66 Billion USD for the item "Stock Based Compensation" represents an increase of 28.91 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -24.05 percent compared to the value the year prior.
The 1 year change in percent is -24.05.
The 3 year change in percent is 93.55.
The 5 year change in percent is 114.29.
The 10 year change in percent is 89.66.

The Serie's long term average value is 0.418 Billion United States Dollars. It's latest available value, on 09/30/2025, is 58.05 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2019, to it's latest available value, on 09/30/2025, is +658.62%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -41.95%.